An Update on Pulmonary Arterial Hypertension

被引:7
作者
Wapner, Joanna [1 ]
Matura, Lea Ann [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 05期
关键词
diagnosis; pathophysiology; pulmonary arterial hypertension; treatment; ORAL TREPROSTINIL; MANAGEMENT; DIAGNOSIS; THERAPY; DISEASE;
D O I
10.1016/j.nurpra.2015.02.004
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Pulmonary arterial hypertension (PAH) is a progressive disease that ultimately leads to right heart failure and death. PAH is defined as a mean pulmonary arterial pressure >= 25 mmHg with a pulmonary capillary wedge pressure <= 15 mmHg at rest. The diagnosis of PAH is one of exclusion; diagnostics include an extensive history, serology, chest radiograph, pulmonary function tests, ventilation/perfusion scan, transthoracic echocardiogram, and right heart catheterization. Treatment and care of patients with PAH can be complex. Therefore, the nurse practitioner is an integral member of the health care team caring for PAH patients, helping to ensure seamless care and support. (C) 2015 Elsevier, Inc. All rights reserved.
引用
收藏
页码:551 / 559
页数:9
相关论文
共 29 条
[1]   The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study [J].
Armstrong, Ian ;
Rochnia, Nikki ;
Harries, Carl ;
Bundock, Sarah ;
Yorke, Janelle .
BMJ OPEN, 2012, 2 (02)
[2]   Predicting Survival in Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) [J].
Benza, Raymond L. ;
Miller, Dave P. ;
Gomberg-Maitland, Mardi ;
Frantz, Robert P. ;
Foreman, Aimee J. ;
Coffey, Christopher S. ;
Frost, Adaani ;
Barst, Robyn J. ;
Badesch, David B. ;
Elliott, C. Gregory ;
Liou, Theodore G. ;
McGoon, Michael D. .
CIRCULATION, 2010, 122 (02) :164-U138
[3]   Endothelial dysfunction in pulmonary hypertension [J].
Budhiraja, R ;
Tuder, RM ;
Hassoun, PM .
CIRCULATION, 2004, 109 (02) :159-165
[4]   Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis [J].
Caldeira, Daniel ;
Loureiro, Maria Jose ;
Costa, Joao ;
Pinto, Fausto J. ;
Ferreira, Joaquim J. .
CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (08) :879-887
[5]  
Chaumais MC, 2013, HANDB EXP PHARMACOL, V218, P161, DOI 10.1007/978-3-642-38664-0_7
[6]   Riociguat: First Global Approval [J].
Conole, Daniel ;
Scott, Lesley J. .
DRUGS, 2013, 73 (17) :1967-1975
[7]   Complex, Chronic, and End-of-Life Care The Interface Between Critical Care and Palliative Care [J].
Freysteinson, Wyona M. .
CRITICAL CARE NURSING QUARTERLY, 2010, 33 (03) :265-272
[8]   Sildenafil citrate therapy for pulmonary arterial hypertension [J].
Galiè, N ;
Ghofrani, HA ;
Torbicki, A ;
Barst, RJ ;
Rubin, LJ ;
Badesch, D ;
Fleming, T ;
Parpia, T ;
Burgess, G ;
Branzi, A ;
Grimminger, F ;
Kurzyna, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157
[9]   Guidelines for the diagnosis and treatment of pulmonary hypertension [J].
Galie, Nazzareno ;
Hoeper, Marius M. ;
Humbert, Marc ;
Torbicki, Adam ;
Vachiery, Jean-Luc ;
Albert Barbera, Joan ;
Beghetti, Maurice ;
Corris, Paul ;
Gaine, Sean ;
Gibbs, J. Simon ;
Angel Gomez-Sanchez, Miguel ;
Jondeau, Guillaume ;
Klepetko, Walter ;
Opitz, Christian ;
Peacock, Andrew ;
Rubin, Lewis ;
Zellweger, Michael ;
Simonneau, Gerald .
EUROPEAN HEART JOURNAL, 2009, 30 (20) :2493-2537
[10]   Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension A Randomized, Controlled Trial [J].
Jing, Zhi-Cheng ;
Parikh, Keyur ;
Pulido, Tomas ;
Jerjes-Sanchez, Carlos ;
White, R. James ;
Allen, Roblee ;
Torbicki, Adam ;
Xu, Kai-Feng ;
Yehle, David ;
Laliberte, Kevin ;
Arneson, Carl ;
Rubin, Lewis J. .
CIRCULATION, 2013, 127 (05) :624-633